# Risk Analysis Report Confirmation

## 0. Document Information
- **Document No.:** 100-005-RAC-001
- **Revision:** 0.1 (Draft)
- **Status:** Pending Review
- **Prepared by:** Kayla Li

## 1. Scope
Final sign-off for the combined risk analysis (DFMEA, PFMEA, UFMEA).

## 2. Conclusion
All residual risks are monitored and balanced against clinical benefits.

---
